Concert Pharmaceuticals OverviewConcert Pharmaceuticals Net Income
Profitability analysis for CNCE.
Quarterly Net Income
-$28.20M
↓ 5.71% YoY
As of Sep 2022
Annual Net Income (TTM)
-$66.45M
↓ 0.21% YoY
Trailing 12 months ending Sep 2022
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...